GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2025-08-22 04:17:37